SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Dorlo Thomas P. C. PhD 1983 )
 

Sökning: WFRF:(Dorlo Thomas P. C. PhD 1983 ) > Pyronaridine :

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003337naa a2200325 4500
001oai:DiVA.org:uu-512437
003SwePub
008230926s2023 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5124372 URI
024a https://doi.org/10.1093/jac/dkad2602 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a for2 swepub-publicationtype
100a Chu, Wan-Yuu Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands.4 aut
2451 0a Pyronaridine :b a review of its clinical pharmacology in the treatment of malaria
264 c 2023
264 1b Oxford University Press,c 2023
338 a electronic2 rdacarrier
520 a Pyronaridine-artesunate was recently strongly recommended in the 2022 update of the WHO Guidelines for the Treatment of Malaria, becoming the newest artemisinin-based combination therapy (ACT) for both uncomplicated Plasmodium falciparum and Plasmodium vivax malaria. Pyronaridine-artesunate, available as a tablet and paediatric granule formulations, is being adopted in regions where malaria treatment outcome is challenged by increasing chloroquine resistance. Pyronaridine is an old antimalarial agent that has been used for more than 50 years as a blood schizonticide, which exerts its antimalarial activity by interfering with the synthesis of the haemozoin pigment within the Plasmodium digestive vacuole. Pyronaridine exhibits a high blood-to-plasma distribution ratio due to its tendency to accumulate in blood cells. This feature is believed to play a crucial role in its pharmacokinetic (PK) properties and pharmacological activity. The PK characteristics of pyronaridine include rapid oral absorption, large volumes of distribution and low total body clearance, resulting in a long terminal apparent half-life. Moreover, differences in PK profiles have been observed between healthy volunteers and malaria-infected patients, indicating a potential disease-related impact on PK properties. Despite a long history, there is only limited knowledge of the clinical PK and pharmacodynamics of pyronaridine, particularly in special populations such as children and pregnant women. We here provide a comprehensive overview of the clinical pharmacology of pyronaridine in the treatment of malaria.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmakologi och toxikologi0 (SwePub)301022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmacology and Toxicology0 (SwePub)301022 hsv//eng
700a Dorlo, Thomas P. C.,c PhD,d 1983-u Uppsala universitet,Institutionen för farmaci,Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands4 aut0 (Swepub:uu)thodo249
710a Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands.b Institutionen för farmaci4 org
773t Journal of Antimicrobial Chemotherapyd : Oxford University Pressx 0305-7453x 1460-2091
856u https://doi.org/10.1093/jac/dkad260y Fulltext
856u https://uu.diva-portal.org/smash/get/diva2:1800390/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-512437
8564 8u https://doi.org/10.1093/jac/dkad260

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...
Chu, Wan-Yu
Dorlo, Thomas P. ...
Om ämnet
MEDICIN OCH HÄLSOVETENSKAP
MEDICIN OCH HÄLS ...
och Medicinska och f ...
och Farmakologi och ...
Artiklar i publikationen
Journal of Antim ...
Av lärosätet
Uppsala universitet

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy